Thyrocare Technologies Limited
THYROCARE
Rank in Stocks
#9598
Thyrocare Technologies Limited, an Indian enterprise, delivers a comprehensive... Thyrocare Technologies Limited, an Indian enterprise, delivers a comprehensive array of diagnostic testing solutions to individual patients, medical laboratories, and healthcare providers throughout the nation. Its operations are structured across three main segments: Diagnostic Testing Services, Imaging Services, and other miscellaneous endeavors. The company's primary focus involves conducting numerous medical diagnostic analyses and specialized test panels aimed at the timely detection and effective management of various health conditions. These include, among others, disorders related to the thyroid, growth, metabolism, autoimmune responses, diabetes, anemia, cardiovascular health, infertility, COVID-19, and a broad spectrum of infectious diseases. Under its "Aarogyam" brand, Thyrocare offers 34 distinct profiles of tests, providing patients with extensive wellness and preventative health check-ups. Furthermore, the company sells "Sugarscan" branded glucometers and glucostrips, along with various consumable products and radiopharmaceuticals. Founded in 1996, Thyrocare Technologies Limited is headquartered in Navi Mumbai, India, and functions as a subsidiary of Docon Technologies Private Limited.
Share Price
$5.17
Last synced: 2026-11-09
Market Cap
$822.19M
Change (1 day)
-1.05%
Change (1 year)
-1.06%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Thyrocare Technologies Limited (THYROCARE)
Category
Healthcare
EPS for Thyrocare Technologies Limited (THYROCARE)
EPS as of September 2026 TTM: $0.10
According to Thyrocare Technologies Limited's latest financial reports, its current EPS (TTM) is $0.10. At the end of 2025 the company had an EPS of $0.20, an increase over its 2024 EPS of $0.16.
EPS history for Thyrocare Technologies Limited from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.10 | -52.45% |
| 2025 | $0.20 | 25.54% |
| 2024 | $0.16 | 8.72% |
| 2023 | $0.15 | -66.26% |
| 2022 | $0.44 | 49.98% |
| 2021 | $0.29 | 31.64% |
| 2020 | $0.22 | -3.27% |
| 2019 | $0.23 | -13.84% |
| 2018 | $0.27 | 116.05% |
| 2017 | $0.12 | -18.71% |
| 2016 | $0.15 | 3.62% |
| 2015 | $0.15 | -16.90% |
| 2014 | $0.18 | -26.36% |
| 2013 | $0.24 | 86.74% |
| 2012 | $0.13 | 23.63% |
| 2011 | $0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | 19,868.45% |
US
|
|
| $6.12 | 6,335.33% |
US
|
|
| $1.38 | 1,348.05% |
CN
|
|
| $14.83 | 15,494.11% |
US
|
|
| $5.09 | 5,252.26% |
US
|
Questions about Thyrocare Technologies Limited's earnings per share (EPS)
What is Thyrocare Technologies Limited's earnings per share (EPS)?
Thyrocare Technologies Limited's earnings per share (EPS) over the last twelve months is $0.10, as of Sep 2026.
What was Thyrocare Technologies Limited's earnings per share (EPS) in 2025?
In 2025, Thyrocare Technologies Limited's earnings per share (EPS) was $0.20, 25.00% more than in 2024 ($0.16).
How has Thyrocare Technologies Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Thyrocare Technologies Limited's earnings per share (EPS) went from $0.22 to $0.20, an average decline of 1.89% a year.
How does Thyrocare Technologies Limited's earnings per share (EPS) compare with similar companies?
Thyrocare Technologies Limited's earnings per share (EPS) ($0.10) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.